Common sense and figures: The rhetoric of validity in medicine Bradford Hill memorial lecture 1999

Statistics in Medicine

Volumn 19, Issue 23, 2000, Pages 3149-3164

  Horton, Richard ^a  

^a THE LANCET   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; MEDICAL DECISION MAKING; MEDICINE; PRACTICE GUIDELINE; REVIEW; SCIENTIFIC LITERATURE; STATISTICS; UNITED KINGDOM;

CLINICAL MEDICINE; CLINICAL TRIALS; CORONARY DISEASE; HUMANS; PUBLICATIONS; REPRODUCIBILITY OF RESULTS; STATISTICS; STENTS;

EID: 0034672283     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0258(20001215)19:23<3149::AID-SIM617>3.0.CO;2-E     Document Type: Review

References (59)

1. Conclusion: The statistician
2. Bibliography: Publications (in English) of Sir Austin Bradford Hill
3. Construction of an abridged life table
4. Maternal rubella and congenital defects
5. Antistreptolysin s titres in rheumatic fever
6. Observations on the response of the pulse rate to exercise in healthy men
7. Smoking and carcinoma of the lung: Preliminary report
8. Chemotherapy of pulmonary tuberculosis in young adults: An analysis of the combined results of three Medical Research Council trials
9. The randomized controlled trial- a British invention
10. Obituary: Austin Bradford Hill
11. Obituary: Sir, Austin Bradford Hill
12. General summary and conclusions
13. Improving the quality of reporting of randomised controlled trials
14. The clinical trial
15. When to act on the evidence
16. Incidence of adverse drug reactions in hospitalised patients
17. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
18. β-blockers for mild to moderate heart failure
19. Interpreting a trial report
20. On small differences in sensation
21. Abduction and induction
22. The Lipid Research Clinics Coronary Prevention Trial results I. Reductions in incidence of coronary heart disease
23. From clinical trials to clinical practice: Generalising from participant to patient
24. Assessing the generalisability of prognostic information
25. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty
26. A comparison of balloon expandable stent implanation with balloon angioplasty in patients with coronary artery disease
27. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease
28. Stenting in chronic coronary occlusion (SICCO): A randomised, controlled trial of adding stent implantation after successful angioplasty
29. A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery
30. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts
31. Intracoronary stenting
32. Intracoronary stenting: From concept to custom
33. Stent-versus-stent equivalency trials
34. Coronary-artery stents-gauging, gorging, and gouging
35. Intracoronary-stent placement for coronary artery disease
36. Indications for intracoronary stent placement: The European view
37. Three year follow-up after implantation of metallic coronary-artery stents
38. Long-term (4 to 6 year) outcome to Palmaz-Schatz stenting: Paucity of late clinical stent-related problems
39. Long-term angiographic and clinical outcome of patients undergoing multivessel coronary stenting
40. Acute and nine-month clinical outcomes after 'suboptimal' coronary stenting: Results from the stent anti-thrombotic regimen study (STARS) registry
41. Assembling comparison groups to assess the effects of health care
42. Why we need observational studies to evaluate the effectiveness of health care
43. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions
44. High-quality clinical databases: Breaking down barriers
45. The clinical trial
46. Grey zones of clinical practice: Some limits to evidence-based medicine
47. The interpretive turn
48. ... So little time, and ..
49. The grammar of interpretive medicine
50. Applying Bayesian ideas to the development of medical guidelines